Ozempic is a member of a new class of medication known as GLP-1 receptor agonists, and its sugar-reducing effect is due to a more direct impact on insulin secretion and slowed gastric emptying, resulting in the GLP-1 medications added bonus of weight loss
If you are interested in being part of that research, this is worth raising directly with your SheMed clinician
Youll leave with a written roadmapwhat medication category were considering, how we plan to titrate, what sideeffects to expect, and the practical standards we use to protect results (protein, hydration, and strength)
Semaglutide binds to GLP-1 receptors on the sinoatrial node and nudges the heart to beat slightly faster
That doesnt mean it hasnt happened, I have just not observed it